Cargando…
Cutaneous Rosai Dorfman disease harboring RET and MAP2K1 mutations, successfully treated with methotrexate
Autores principales: | Konstantinou, Maria P., Tournier, Emilie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790644/ https://www.ncbi.nlm.nih.gov/pubmed/35569068 http://dx.doi.org/10.1111/ijd.16269 |
Ejemplares similares
-
Rosai-Dorfman disease successfully treated with thalidomide
por: Chen, Edward, et al.
Publicado: (2016) -
Recurrent Cutaneous Rosai-Dorfman Disease
por: Michaeli, Oren, et al.
Publicado: (2019) -
Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
por: Fay, Christopher J., et al.
Publicado: (2023) -
Purely Cutaneous Rosai-Dorfman Disease with Immunohistochemistry
por: Farooq, Uzma, et al.
Publicado: (2013) -
Primary Cutaneous Rosai-Dorfman Disease of the Scalp
por: Mizuta, Haruki, et al.
Publicado: (2020)